Washington, DC (May 11, 2018) – BIO President and CEO Jim Greenwood issued the following statement after President Trump announced his administration’s plan to lower prescription drug costs: “The men and women of the biopharmaceutical industry work every day to help cure disease and improve the lives of patients.
BIO Statement on Trump Administration’s Plan to Lower Drug Costs “We have concerns that some of the ideas proposed today could, if adopted, hurt patient access to the medicines they need …”
BIO Statement on Trump Administration’s Plan to Lower Drug Costs : Last week the president outlined some of the financial challenges patients face at the pharmacy counter. We look forward to working with the administration on solutions that help provide all patients access to prescription drugs with out-of-pocket costs they can afford.
Watch video · President Donald Trump unveiled his administration’s plan to lower drug prices. Trump has repeatedly chastised drug companies, even accusing them of ”getting away with murder.” Health and Human Services Secretary Alex Azar told CNBC on Friday everyone’s benefiting from high drug prices except patients and taxpayers.
T he Trump administration made several moves Monday aimed at lowering drug costs under Medicare for seniors. The Centers for Medicare and Medicaid Services announced final policies for Medicare health and drug plans for 2019, part of a larger effort to lower Medicare drug costs.
Trump: ‘Unacceptable’ that some drugs cost more in US than overseas. President Donald Trump unveils his plan to lower the cost of prescription drug prices.
President Trump’s plan to bring down prescription drug costs is the “most comprehensive” of any president in history, official says Tuesday, June 12, 2018 by: Ethan Huff Tags: alex azar , Big Pharma , Donald Trump , lowering costs , pharmaceutical drugs , prescriptions , prices , reform , Trump administration
For Medicare Part D plans, 100 percent of the rebates are passed through to lower premiums, which reduces costs for both the beneficiary and the government. The tools used by pharmacy benefit managers to remove costs from the health care system are projected to save $654 billion on drug costs over the next decade.
BUILDING ON ADMINISTRATION EFFORTS: The blueprint will build upon actions President Trump’s Administration has already taken to increase competition and curb high drug prices. FDA’s 2017 generic drug approvals contributed to prescription drug buyers saving $8.8 billion.
WOONSOCKET, R.I., May 11, 2018 /PRNewswire/ — In response to President Trump’s special address on the high cost of prescription drugs, CVS Health today issued the following statement: ”At CVS Health we see every …